Curocell Inc
372320
Company Profile
Business description
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.
Contact
11, Gukjegwahak 16-ro
Yuseong-gu
Daejeon34002
KORT: +82 428633698
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
140
Stocks News & Analysis
stocks
Earnings up but shares overvalued for ASX gold miner
Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
We see faster cloud growth and improved longer-term profitability for Alphabet.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,351.90 | 4.90 | -0.05% |
| CAC 40 | 8,230.41 | 4.78 | 0.06% |
| DAX 40 | 24,258.62 | 18.73 | 0.08% |
| Dow JONES (US) | 47,444.97 | 237.85 | 0.50% |
| FTSE 100 | 9,635.56 | 10.06 | -0.10% |
| HKSE | 26,433.70 | 273.55 | 1.05% |
| NASDAQ | 23,566.29 | 361.42 | 1.56% |
| Nikkei 225 | 50,512.32 | 1,212.67 | 2.46% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,854.61 | 62.92 | 0.93% |
| S&P/ASX 200 | 9,055.60 | 2.20 | -0.02% |
| SSE Composite Index | 3,996.94 | 46.63 | 1.18% |